VANGUARD GROUP INC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$91,148,000
+3.3%
769,761
+3.0%
0.00%
-33.3%
Q4 2020$88,236,000
-5.6%
747,065
-11.2%
0.00%0.0%
Q3 2020$93,504,000
+0.5%
841,317
-7.6%
0.00%0.0%
Q2 2020$93,027,000
-13.2%
910,408
-8.3%
0.00%
-40.0%
Q1 2020$107,135,000
-2.5%
992,643
+5.1%
0.01%
+25.0%
Q4 2019$109,931,000
+6.6%
944,591
+4.9%
0.00%0.0%
Q3 2019$103,100,000
+13.8%
900,670
-5.2%
0.00%
+33.3%
Q2 2019$90,575,000
+7.7%
950,421
+3.2%
0.00%0.0%
Q1 2019$84,063,000
+23.1%
921,243
+2.4%
0.00%0.0%
Q4 2018$68,288,000
-2.3%
899,592
+3.0%
0.00%0.0%
Q3 2018$69,884,000
-10.1%
873,552
+11.6%
0.00%0.0%
Q2 2018$77,777,000
+34.8%
783,020
+9.9%
0.00%0.0%
Q1 2018$57,692,000
+4.7%
712,244
+1.8%
0.00%
+50.0%
Q4 2017$55,110,000
+11.3%
699,628
+30.4%
0.00%0.0%
Q3 2017$49,515,000536,6330.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2019
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders